*Brown SR, Tiernan JP, Watson AJM, et al. Haemorrhoidal artery ligation versus rubber band ligation for the management of symptomatic second-degree and third-degree haemorrhoids (HubBLe): a multicentre, open-label, randomised controlled trial.* Lancet *2016; **388:** 356--64*---In this Article, the results for mean EQ-5D utility score should have been: "For RBL the mean at day 1 was 0·84 (SD 0·19) and at day 7 it was 0·92 (0·15)...with the mean being 0·76 (0·22) at day 1 and 0·83 (0·18) at day 7. The adjusted difference in means were 0·08 (95% CI 0·04--0·13; p\<0·001) at day 1 and 0·08 (0·05--0·12; p\<0·001) at day 7. The mean health utility was [nearly]{.ul} similar [with no statistical differences]{.ul} between the two groups (and above baseline values) at all timepoints from day 21 onwards." In the Discussion section, the following sentence has been clarified: "Even if a difference in recurrence is assumed, (ie, single RBL procedure vs HAL) the cost-effectiveness [in terms of cost per recurrence avoided]{.ul} is approximately £5000". This correction has been made to the online version as of July 21, 2016, and the printed version is correct.
